Hospital-acquired Pneumonia Clinical Trials

49 clinical trials for Hospital-acquired Pneumonia across international registries, including 10 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Pneumonia After Cardiovascular Surgery With Artificial Intelligence — RECRUITING
• Acyclovir in Ventilated Patients With Pneumonia and HSV-1 in BAL — RECRUITING · PHASE3
• Dexamethasone for treating severe hospital-acquired pneumonia in critically ill patients with a proinflammatory phenotype, an international phase III, double-blind, placebo-controlled, randomized trial - the HAP-DEX study — RECRUITING · PHASE3
• Predictors and Outcomes of Ventilated Hospital-acquired Pneumonia — RECRUITING
• Long-term Alterations of Host-microbiome Interactions and Cardiovascular and Respiratory Diseases Progression After Pneumonia — RECRUITING · NA
• Real-World Effectiveness of Aztreonam-Avibactam Against MBL-Producing CRE — RECRUITING
• A Study to Learn About the Study Medicine Zavicefta After it is Released Into the Markets in Korea — RECRUITING
• Dexamethasone for Treating Severe Hospital-acquired Pneumonia in Critically Ill Patients With a Proinflammatory Phenotype — RECRUITING · PHASE3
• Pneumonia Pathogens' Virulence Factors, Patient Inflammatory Markers, and Their Associations With Outcomes — RECRUITING
• EaRly impAct theraPy With Ceftazidime-avibactam Via rapID Diagnostics — RECRUITING · PHASE4
• Trial on a Strategy Combining Rapid Diagnostic Testing and Antimicrobial Stewardship to Improve Antibiotic Use in Patients With Hospital-acquired Pneumonia. — COMPLETED · NA
• Identifying Risk Factors for Gram-negative Resistance for HAP/VAP in the Intensive Care Unit — COMPLETED
• Steriwave ICU Pilot Study — COMPLETED · NA
• A Study to Assess the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses of Cefiderocol in Hospitalized Pediatric Participants — COMPLETED · PHASE2
• Feasibility Study of Contemporary Diagnostics for Patients With Suspected Hospital-Acquired Pneumonia. — COMPLETED · NA
• Real-World Study of Ceftazidime Avibactam in China — TERMINATED
• Cefepime-taniborbactam vs Meropenem in Adults With VABP or Ventilated HABP — WITHDRAWN · PHASE3
• Efficacy and Safety of CAZ-AVI in the Treatment of Infections Due to Carbapenem-resistant G- Pathogens in Chinese Adults — COMPLETED · PHASE4
• Efficacy and Safety of Ceftazidime-Avibactam (CAZ-AVI) in Chinese Participants With HAP (Including VAP) — COMPLETED · PHASE4
• Use of Presepsin as a Marker for Immunotherapy Administration in Pneumonia — COMPLETED · PHASE2
• Effect of Angulus on Patient-elevation Compliance — COMPLETED · NA
• Diagnostic Performance and Impact of a Multiplex PCR Pneumonia Panel in ICU Patients With Severe Pneumonia. — COMPLETED
• Efficacy of Intravenous Amboxol Hydrochloride as an Adjunct Therapy for Severe Pneumonia in Critically Ill Patients — COMPLETED · PHASE4
• HOspital NEtwork STudy - Preparation for a Randomized Evaluation of Anti-Pneumonia Strategies — COMPLETED
• Chinese Hospital Acquired Pneumonia Collaboration Network: Epidemiology, Diagnosis and Treatment — NOT_YET_RECRUITING
• "Baricitinib for Treating Hospital-acquired Pneumonia in Critically Ill Patients With a Proinflammatory Phenotype. — OTHER · PHASE2
• Ceftobiprole in the Treatment of Pediatric Patients With Pneumonia — COMPLETED · PHASE3
• Hospital Acquired Pneumonia in Temporary Tracheostomy — OTHER
• HOME FIRST Pilot: a Study of Early Supported Discharge in Patients With Lower Respiratory Tract Infections — COMPLETED · NA
• Impact of Antimicrobial Stewardship on Outcomes of Patients With Hospital-acquired Pneumonia Due to Gram-negative Bacilli - A Before-after Study — COMPLETED
• 0.12% Chlorhexidine Oral Care for the Prevention of Non-ventilator Hospital-acquired Pneumonia — COMPLETED · NA
• Comprehensive Molecular Diagnosis and Management of Hospital- and Ventilator-associated Pneumonia in Norway — OTHER
• Study of Cefiderocol (S-649266) or Best Available Therapy for the Treatment of Severe Infections Caused by Carbapenem-resistant Gram-negative Pathogens — COMPLETED · PHASE3
• Clinical Study of Cefiderocol (S-649266) for the Treatment of Nosocomial Pneumonia Caused by Gram-negative Pathogens — COMPLETED · PHASE3
• Modular Prevention Bundle for Non-ventilator-associated Hospital-acquired Pneumonia (nvHAP) — TERMINATED · NA
• Hospital-acquired Pneumonia in Intensive Care Unit — COMPLETED
• Comparison of Solid Organ Transplant — OTHER
• A Study of Meropenem-Vaborbactam Versus Piperacillin/Tazobactam in Participants With Hospital-Acquired and Ventilator-Associated Bacterial Pneumonia — WITHDRAWN · PHASE3
• Targeting Platelet-Leukocyte Aggregates in Pneumonia With Ticagrelor — COMPLETED · PHASE1
• Validity of Biological Material Sampling in Patients With Hospital-acquired Pneumonia — COMPLETED
• Does Cricoid Pressure Reduce the Risk of Aspiration? — COMPLETED · NA
• E Test Strips Applied to Bronchoalveolar Lavage for Suspicion of Hospital-acquired Pneumonia to Accelerate Antibiogram Analysis. — COMPLETED · NA
• Early Mobility Bundle to Prevent Hospital Acquired Pneumonia (HAP) in Medical Inpatients — COMPLETED · NA
• The Impact of Simultaneous Presence of Viral and Bacterial Pathogens on Therapy and Course of Severe Pneumonia — OTHER
• Evaluation of Patients With Methicillin-Resistant Staphylococcus Aureus Hospital-Acquired Pneumonia Treated With Linezolid or Vancomycin — COMPLETED
• Detection of Pneumonia associated Pathogens and Antibiotic Resistance Genes using the Curetis Unyvero® Pneumonia Application — OTHER
• Efficacy and Safety of Colistimethate Sodium Injection Vial to Treat Hospital-acquired Pneumonia in Adults — OTHER · PHASE2
• Colistin and Rifampicin for MDR-Acinetobacter — COMPLETED · PHASE3
• Clinical Efficacy of Intravenous Iclaprim Versus Vancomycin in the Treatment of Hospital-Acquired, Ventilator-Associated, or Health-Care-Associated Pneumonia — TERMINATED · PHASE2

Refine this search